CLOs on the Move

ITC Nexus Dx

www.itcmed.com

 
ITC is a wholly-owned subsidiary of Thoratec and develops, manufactures and markets medical devices used in three distinct segments of the medical field.
  • Number of Employees: 25-100
  • Annual Revenue: $250-500 Million
  • www.itcmed.com
  • 8 Olsen Ave
    Edison, NJ USA 08820-2419
  • Phone: 732.548.5700

Executives

Name Title Contact Details

Similar Companies

Pointe Scientific

Pointe Scientific Inc. is a Canton, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Diligent Robotics

We are a human-centered robotics company. Our mission is to make technical advances towards robots and humans working together side by side, with an emphasis on human-centric design. Diligent Robotics is developing a suite of artificial intelligence that enables robots to collaborate with and adapt to humans in everyday environments.

Aware Recovery Care

Our mission at Aware Recovery Care is to help people affected by addiction “Recover Where You Live”. At Aware Recovery Care, we transform the home into a treatment center, delivering innovative addiction services to those in need, where they live. We treat addiction like a chronic illness, and our groundbreaking and evidence-based treatment approach provides comprehensive care from a multidisciplinary team of clinicians led by an Addiction Psychiatrist, a Family Systems Therapist, and a Registered Nurse. And with the help of a Certified Recovery Advisor, we help our clients learn new skills and daily habits required to maintain abstinence, while remaining amongst family and friends in their community, thereby avoiding the oftentimes difficult return home from traditional treatment options. Privacy and anonymity are respected, and dignity is preserved as we provide care that is discreet and effective. Authenticity, empathy, purpose, and thoughtfulness are at the heart of everything we do, and we seek deeply passionate people who are committed to immersing themselves in our mission. Those who are up for the task will be rewarded with rewarding mission-oriented workdays, and a voice at the table helping to build a transformational business entering a hypergrowth stage. Come join us as we create a preferred destination for top talent in the Healthcare community and set a new standard for the treatment of SUD. In early 2021, Aware received an investment by Health Enterprise Partners (HEP), a growth equity firm whose investors include some of the largest health systems and health insurance plans in the United States. Aware now operates in nine states (CT, MA, RI, NH, ME, VA, OH, IN, FL) and is poised for hyper-growth and national expansion in partnership with established national and regional payors, employers, and other stakeholders.

Persivia

The Persivia® platform allows IDNs, hospitals, and physician practices to increase revenue, improve quality and succeed under MIPS, CPC+, ACO, OCM and other CMS and commercial value-based payment models.

OncoCell MDx

OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.